[1]
P. Mashayekhi, M. Noruzinia, and S. Khodaverdi, “Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study”, IJRM, vol. 20, no. 10, pp. 861–872, Nov. 2022.